Cord Blood Units with Low CD34+ Cell Viability Have a Low Probability of Engraftment after Double Unit Transplantation

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 4, 2010, Pages 500-508

  Scaradavou, Andromachi ^a   Smith, Katherine M ^b   Hawke, Rebecca ^a   Schaible, Allison ^b   Abboud, Michelle ^c   Kernan, Nancy A ^a   Young, James W ^a   Barker, Juliet N ^a  

^a Memorial Sloan Kettering   (United States)

^b Department of Clinical Laboratories ^*  (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL VIABILITY; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; MYELOABLATIVE CONDITIONING; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE CONDITIONING; PROLYMPHOCYTIC LEUKEMIA; PROSPECTIVE STUDY; SCHOOL CHILD; ALLOTRANSPLANTATION; BLOOD; BLOOD STORAGE; CELL SURVIVAL; CYTOLOGY; FEMALE; FETUS BLOOD; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BLOOD PRESERVATION; CELL SURVIVAL; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77649339493     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.11.013     Document Type: Article

References (24)

1. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337 (1997) 373-381
2. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
3. Wagner J.E., Barker J.N., DeFor T.E., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100 (2002) 1611-1618
4. Kurtzberg J., Prasad V.K., Carter S.L., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 112 (2008) 4318-4327
5. Barker J.N., Verfaillie C.M., McGlave P., et al. Creation of a double chimera by transplantation of two unrelated donor umbilical cord blood units. Blood 96 (2000) 207a
6. De Lima M., St John L.S., Wieder E.D., et al. Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol 119 (2002) 773-776
7. Barker J.N., Weisdorf D.J., DeFor T.E., Blazar B.R., Miller J.S., and Wagner J.E. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102 (2003) 1915-1919
8. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105 (2005) 1343-1347
9. Ballen K.K., Spitzer T.R., Yeap B.Y., et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 13 (2007) 82-89
10. Brunstein C., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after non-myeloablative conditioning: impact on transplant outcomes in 110 adults with hematological disease. Blood 110 (2007) 3064-3070
11. Rodrigues C.A., Sanz G., Brunstein C.G., et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol 27 (2009) 256-263
12. Verneris M.R., Brunstein C., Barker J.N., et al. Relapse risk after umbilical cord blood transplantation: enhanced graft versus leukemia effect in recipients of two units. Blood (2009) (in press)
13. Rubinstein P., Dobrila L., Rosenfield R.E., et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 92 (1995) 10119-10122
14. Barker J.N., Abboud M., Rice R.D., et al. A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions. Biol Blood Marrow Transplant (2009) (in press)
15. Sutherland D.R., Anderson L., Keeney M., Nayar R., and Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5 (1996) 213-226
16. Gratama J.W., Orfao A., Barnett D., et al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 34 (1998) 128-142
17. Keeney M., Gratama J.W., Chin-Yee I.H., and Sutherland D.R. Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry-time to let go!. Cytometry 34 (1998) 280-283
18. Yoo K.H., Lee S.H., Kim H.J., et al. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant 39 (2007) 515-521
19. Keeney M., and Sutherland D.R. Stem cell enumeration by flow cytometry: current concepts and recent developments in CD34+ cell enumeration. Cytotherapy 2 (2000) 395-402
20. Sutherland D.R., Nayyar R., Acton E., Giftakis A., Dean S., and Mosiman V.L. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers. Cytotherapy 11 (2009) 595-605
21. Koehl U., Bochennek K., Esser R., et al. ISHAGE-based single-platform flow cytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56 + CD3- NK cells. Int J Hematol 87 (2008) 98-105
22. Brunstein C.G., Setubal D.C., and Wagner J.E. Expanding the role of umbilical cord blood transplantation. Br J Haematol 137 (2007) 20-35
23. Chan K.W., Grimley M.S., Taylor C., and Wall D.A. Early identification and management of graft failure after unrelated cord blood transplantation. Bone Marrow Transplant 42 (2008) 35-41
24. Eldjerou L.K., Chaudhury S., He M., et al. Graft-vs-graft immune interaction is the likely mechanism of absolute unit dominance in double-unit cord blood (DCB) transplantation using patient DCB grafts: an in vivo but not in vitro phenomenon. Blood 112 (2008) 1195a